TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
This Quarter Return
+4.21%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$254M
AUM Growth
–
Cap. Flow
+$78.3M
Cap. Flow
% of AUM
30.86%
Top 10 Holdings %
Top 10 Hldgs %
85.82%
Holding
21
New
12
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
$19.8M |
| 2 |
Nektar Therapeutics
NKTR
|
$10.5M |
| 3 |
Assertio
ASRT
|
$10.4M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
$10.2M |
| 5 |
Achieve Life Sciences
ACHV
|
$9.14M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 22.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SLXP
1
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $19.8M | 7.82% | +300,000 | New | +$19.8M |
|
|
2
Nektar Therapeutics
NKTR
$568M
| $10.5M | 4.15% | +911,053 | New | +$10.5M |
|
|
3
Assertio
ASRT
$80.4M
| $10.4M | 4.08% | +1,842,280 | New | +$10.4M |
|
|
4
BioMarin Pharmaceuticals
BMRN
$11.2B
| $10.2M | 4% | +182,300 | New | +$10.2M |
|
|
5
Achieve Life Sciences
ACHV
$152M
| $9.14M | 3.6% | +933,100 | New | +$9.14M |
|
6
MannKind Corp
MNKD
$1.41B
| $7.71M | 3.04% | +1,184,784 | New | +$7.71M |
|
|
ECYT
7
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $6.12M | 2.41% | +465,763 | New | +$6.12M |
|
|
NAVB
8
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
| $2.32M | 0.91% | +868,079 | New | +$2.32M |
|
9
Rockwell Medical
RMTI
$58.9M
| $1.62M | 0.64% | +448,146 | New | +$1.62M |
|
|
DNDN
10
DELISTED
DENDREON CORPORATION
DNDN
| $328K | 0.13% | +79,600 | New | +$328K |
|
11
Cyclacel Pharmaceuticals
CYCC
$18.4M
| $218K | 0.09% | +73,895 | New | +$218K |
|
|
AMBI
12
DELISTED
AMBIT BIOSCIENCES CORP COM STK (DE)
AMBI
| $0 | ﹤0.01% | +46 | New | – |
|